FOLLOW US

Type 1 Diabetes Research Updates

For Medical Professionals

Overcoming barriers to sleep and assisting families with sleep hygiene aids in glucose management
Technology Accessibility in Type 1 Diabetes Differs By Race and Needs to be Addressed to Decrease Health Disparities
Instead of suppressing the immune system, this new approach engages it
The pump system has proved to improve the length of time users spend in ideal glucose range
Advances in stem cell transplantation may replace the need for insulin in type 1 diabetes and may lead to repair of damaged heart tissue following a heart attack.
For people who continue to have life-altering severe hypoglycemia despite optimal medical management, islet transplantation offers a potentially lifesaving treatment .
Type 1 diabetes is associated with an increased risk of some cancer types, including cancer of the stomach, but a reduced risk of other cancer types, including prostate and breast cancer.
A new approach for staging T1D in its earliest presymptomatic stages was released by the JDRF, the Endocrine Society, and the American Diabetes Association. The organizations endorse the concept that autoimmune disease precedes the onset of symptoms and progresses through distinct stages.
A minority of adults and caregivers of children with type 1 diabetes routinely download and review data from diabetes devices, according to data from a cross-sectional survey published in Diabetes Technology and Therapeutics.
People with type 1 diabetes are at increased risk for celiac disease (CD), particularly in the early course of diabetes, according to findings from a systematic review of the literature.
Mealtime insulin dosing calculation should focus on meal composition—including fat, protein, and glycemic index—rather than carbohydrate counting alone, according to a systematic review published in the June issue of Diabetes Care.
DreaMed Diabetes has signed a licensing agreement with Medtronic that will allow its closed-loop artificial pancreas technology, called GlucoSitter™, to be used in Medtronic’s insulin pumps.
Management of type 1 diabetes is particularly challenging during adolescence, a time when teens are dealing with physical changes among other issues.
A clinical trial is examining whether an artificial pancreas improves nighttime blood glucose levels in patients with type 1 diabetes.
Researchers discussed the latest advances in cell replacement therapy for the treatment of type 1 diabetes in the January issue of Endocrinology.
The findings of this important paper emphasize one specific word: early. It is important to treat these patients with type 1 aggressively and early, when they are either adolescent or young adults, or as soon as they are diagnosed if they are diagnosed in their 20s.
The U.S. Food and Drug Administration (FDA) approved for marketing the first zinc transporter 8 autoantibody (ZnT8Ab) test to aid in the diagnosis of type 1 diabetes.
High albumin levels, but within the normal range, can be used to identify young people with type 1 diabetes at risk of heart and kidney disease.
close X
SHOW MAIN MENU
SHOW SUB MENU